Your browser doesn't support javascript.
loading
Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group.
Ooms, Ariadne H A G; Gadd, Samantha; Gerhard, Daniela S; Smith, Malcolm A; Guidry Auvil, Jaime M; Meerzaman, Daoud; Chen, Qing-Rong; Hsu, Chih Hao; Yan, Chunhua; Nguyen, Cu; Hu, Ying; Ma, Yussanne; Zong, Zusheng; Mungall, Andrew J; Moore, Richard A; Marra, Marco A; Huff, Vicki; Dome, Jeffrey S; Chi, Yueh-Yun; Tian, Jing; Geller, James I; Mullighan, Charles G; Ma, Jing; Wheeler, David A; Hampton, Oliver A; Walz, Amy L; van den Heuvel-Eibrink, Marry M; de Krijger, Ronald R; Ross, Nicole; Gastier-Foster, Julie M; Perlman, Elizabeth J.
Affiliation
  • Ooms AH; Department of Pathology and Laboratory Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois.
  • Gadd S; Princess Maxima Centre for Pediatric Oncology, Utrecht, the Netherlands.
  • Gerhard DS; Department of Pathology, Pathan BV, Sint Franciscus Gasthuis, Rotterdam, the Netherlands.
  • Smith MA; Department of Pathology and Laboratory Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois.
  • Guidry Auvil JM; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland.
  • Meerzaman D; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland.
  • Chen QR; Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland.
  • Hsu CH; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland.
  • Yan C; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland.
  • Nguyen C; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland.
  • Hu Y; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland.
  • Ma Y; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland.
  • Zong Z; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland.
  • Mungall AJ; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency (BCCA), Vancouver, British Columbia, Canada.
  • Moore RA; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency (BCCA), Vancouver, British Columbia, Canada.
  • Marra MA; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency (BCCA), Vancouver, British Columbia, Canada.
  • Huff V; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency (BCCA), Vancouver, British Columbia, Canada.
  • Dome JS; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency (BCCA), Vancouver, British Columbia, Canada.
  • Chi YY; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
  • Tian J; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Geller JI; Division of Pediatric Hematology/Oncology, Children's National Medical Center, Washington, DC.
  • Mullighan CG; Department of Biostatistics, University of Florida, Gainesville, Florida.
  • Ma J; Department of Biostatistics, University of Florida, Gainesville, Florida.
  • Wheeler DA; Division of Pediatric Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
  • Hampton OA; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • Walz AL; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee.
  • van den Heuvel-Eibrink MM; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
  • de Krijger RR; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
  • Ross N; Division of Hematology-Oncology and Transplantation, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University's Feinberg School of Medicine, Chicago, Illinois.
  • Gastier-Foster JM; Northwestern Medicine Developmental Therapeutics Institute, Northwestern Memorial Hospital, Chicago, Illinois.
  • Perlman EJ; Princess Maxima Centre for Pediatric Oncology, Utrecht, the Netherlands.
Clin Cancer Res ; 22(22): 5582-5591, 2016 Nov 15.
Article in En | MEDLINE | ID: mdl-27702824
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radius / Tumor Suppressor Protein p53 / Wilms Tumor / Anaplasia / Kidney Neoplasms / Mutation Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radius / Tumor Suppressor Protein p53 / Wilms Tumor / Anaplasia / Kidney Neoplasms / Mutation Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2016 Document type: Article Country of publication: United States